Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice

Bone

Volumn 27, Issue 6, 2000, Pages 811-817

  Kinoshita, T ^a   Kobayashi, S ^a   Ebara, S ^a   Yoshimura, Y ^a   Horiuchi, H ^a   Tsutsumimoto, T ^a   Wakabayashi, S ^a   Takaoka, K ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone formation; Cyclic AMP; Pentoxifylline; Phosphodiesterase; Rolipram

Indexed keywords

CYCLIC AMP; ENZYME INHIBITOR; PENTOXIFYLLINE; PHOSPHODIESTERASE; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DENSITOMETRY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; X RAY;

ANIMALS; BONE REMODELING; DENSITOMETRY, X-RAY; FEMUR; LUMBAR VERTEBRAE; MALE; MICE; MICE, INBRED BALB C; PARATHYROID HORMONE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; ROLIPRAM; TIBIA;

EID: 0033711976     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00395-1     Document Type: Article

References (50)

1. Cyclic adenosine 3'5'-monophosphate (cAMP) dependent and cAMP independent regulation of parathyroid hormone receptors on UMR 106-01 osteoblastic osteosarcoma cells
2. Regulation of adenosine 3',5'-cyclic monophosphate (cAMP) accumulation in UMR-106 osteoblast-like cells; role of cAMP-phosphodiesterase and cAMP efflux
3. Rapid protein kinase A-mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells
4. Cyclic nucleotide phosphodiesterases; functional implications of miltiple isoforms
5. Pentoxifylline selectively inhibits tumor necrosis factor synthesis in the arterial wall
6. Stimulation of bone resorption and inhibit of bone formation in vitro by human tumour necrosis factors
7. Single-cell analysis of cyclic AMP response to parathyroid hormone in osteoblastic cells
8. Recent progress in understanding the hormonal regulation of phosphodiesterases
9. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP-phosphodiesterase in rat fat cells by phosphorylation
10. Pentoxifylline suppression of tumor necrosis factor gene transcription
11. Cyclic nucleotides differentially regulate the synthesis of tumor necrosis factor-α and interleukin-1β by human mononuclear cells
12. Effect of human parathyroid hormone (PTH (1-34)) on experimental osteopenia of rats induced by ovariectomy
13. Evaluation of the risk of hip fracture
14. The functional block of TNF but not of IL-6 prevents bone loss in ovariectmized mice
15. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production
16. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats
17. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice
18. Hormonal regulation of collagen synthesis in a clonal rat osteosarcoma cell line
19. Hip fractures; incidence, risk factors, energy absorption, and prevention
20. Human parathyroid hormone- (1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats
21. Alkaline phosphatase inhibition by parathyroid hormone and isoproterenol in a clonal rat osteosarcoma cell line; Possible mediation by cyclic AMP
22. Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from liver plasma-membranes
23. Heterogeneity of age-related fractures; implications for epidemiology
24. Mechanisms of homologous and heterologous regulation of parathyroid hormone receptors in the rat osteosarcoma cell line UMR-106
25. Reduction of bone loss by Denbufylline, an inhibitor of phosphodiesterase 4
26. Modulation of TNFα and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors
27. Pentoxifylline in vivo down regulates the release of IL-1β, IL-6, IL-8 and tumor necrosis factor-α by human peripheral blood monouclear cells
28. Bone histomorphometry; standardization of nomenclature, symbols, and units
29. Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression
30. Parathyroid hormone inhibits collagen synthesis at both ribonucleic acid and protein levels in rat osteogenic sarcoma cells
31. L'osteopetrose ou maladie des os marmoreens
32. Characterization of cAMP-dependent inhibition of LPS-induced TNF-α production by Rolipram, a specific phosphodiesteraseIV inhibitor
33. Desensitization of parathyroid hormone reseptors on cultured bone cells
34. Analysis of gene expression in human bone biopsies by polymerase chain reaction; evidence for enhanced cytokine expression in postmenopausal osteoporosis
35. Parathyroid hormone fragments may stimulate bone groeth in ovariectomized rats by activating adenylyl cyclase
36. Age-related differences in cytokine secretion
37. The specific type IV phosphodiesterase inhibitor Rolipram suppresses tumor necrosis factor-α production by human mononuclear cells
38. Xanthine derivatives; comparison between supression of tumor necrosis factor-α production and inhibition of cAMP phosphodiesterase activity
39. Cellular and molecular regulation of tumor necrosis factor alpha production by pentoxifylline
40. On the stimulation of new bone-formation with parathyroid extract and irradiated ergosterol
41. The short-term activation of a rolipram-sensitive. AAMP-specific phosphodiesterase by thyroid stimulating hormone in thyroid FRTL-5 cells is mediated by cAMP-dependent phosphorylation
42. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol
43. Periosteal and intratumorous bone formation in athymic nude mice by chinese hamster ovary tumors expressing murine bone morphogenetic protein-4
44. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action; Differential effects of intermittent and continuous administration
45. Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-α, IL-1β and IL-10 by human leucocytes
46. A versatile new mineralized bone stain for simultaneous assessment of tetracycline and osteoid seams
47. A new Goldner's one-step trichrome stain for identification of osteoid stems, bone and cells in undecalcified, plastic embedded sections of bone
48. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats
49. Activation of protein kinase A is a pivotal step involved in both BMP-2 and cyclic AMP-induced chondrogenesis